期刊文献+

颞叶癫痫术后单药应用卡马西平与奥卡西平的临床对比研究 被引量:4

Comparison study of Carbamazepine and Oxcarbazepine after Temporal Lobe Epilepsy Surgery as Monotherapy
下载PDF
导出
摘要 目的通过颞叶癫痫术后单药应用奥卡西平与卡马西平的对比研究,评价两者在疗效、不良反应方面的差异。方法将363例颞叶癫痫术后患者按治疗用药分为奥卡西平组209例和卡马西平组154例。观察2组术后2年癫痫的控制效果及术后药物不良反应发生情况,并进行对比分析。结果奥卡西平组术后癫痫控制效果略高于卡马西平组,但差异无统计学意义(P>0.05)。奥卡西平组不良反应发生率为7.7%,明显低于卡马西平组的14.9%,差异有统计学意义(P<0.05)。结论颞叶癫痫术后单用奥卡西平的癫痫控制效果与卡马西平相同,但不良反应发生率明显低于卡马西平。 Objective To assess the efficacy and side effect of CBZ (Carbamazepine) and OXC (Oxcarbazepine) af- ter temporal lobe epilepsy surgery. Methods 363 patients with temporal lobe epilepsy surgery were randomly divided into CBZ group ( 154 cases) and OXC group (209 cases). All patients had been followed up 2 years in order to investigate the surgery outcomes and the efficacy and side effect were observed. Results Postoperative seizure control effect in Oxcarbazepine group was slightly higher than that of the carbamazepine group, but the difference was not statistically significant ( P 〉 0.05 ). The incidence of adverse reactions rate in Oxcarbazepine group was 7.7%, significantly lower than that in the carbamazepine group ( 14.9% ), and the difference was statistically significant (P 〈 0.05). Conclusion Both CBZ and OXC are effective in trea- ting the patients after the temporal lobe epilepsy surgery,but the OXC has fewer side effect than the CBZ.
出处 《临床合理用药杂志》 2012年第14期16-18,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 奥卡西平 卡马西平 颞叶癫痫手术 癫痫控制 不良反应 Oxcarbazepine Carbamazepine Operation temporal lobe epilepsy Seizure control Adverse reaction
  • 相关文献

参考文献13

二级参考文献36

  • 1朱乐亭,赵志刚.曲莱[J].中国新药杂志,2004,13(8):754-755. 被引量:6
  • 2罗昱,肖绍文.难治性癫痫的外科治疗及术前评估[J].国际神经病学神经外科学杂志,2006,33(3):225-228. 被引量:8
  • 3全国神经外科癫痫防治协助组,周良辅,郑康,卢亦成,王硕,刘伟国,张祖勇,史继新,李昭杰,徐如祥,漆松涛,章翔,杨卫忠.神经外科围手术期和外伤后癫痫的预防及治疗指南(草案)[J].中华神经医学杂志,2006,5(12):1189-1190. 被引量:54
  • 4Raju GP,Sarco DP, Poduri A. Oxcarbazepine in children with nocturnal frontal - lobe epilepsy[J]. Pediatr Neurol, 2007,37 ( 5 ) :345 - 349.
  • 5Schdeo R, Beydaun A, Schachter S, et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures [ J ]. Neurology, 2001,57 (5) :864 -871.
  • 6Coppola G,Franzoni E,Verrotti A,et al. Levetiracetam or oxearbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes ( BECTS ) : An open - label, parallel group trial [J]. Brain Dev,2007,29(5 ) :281 - 284.
  • 7Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group[ J]. Neurology,2000,54(12) :2237 -2244.
  • 8Bares G, Walkcr EB, Elger CE,et al. Oxcarbazepine placebo -controlled, dose - ranging trial in refractory partial epilepsy [ J ]. Epilepsia, 2000,41 (12) :1597 - 1607.
  • 9Tutor - Crespo M J, Hermida J, Tutor JC. Relation of blood platelet count during carbamazepine and oxcarbazepine treatment with daily dose, and serum concentrations of carbamazepine, carbamazepine - 10,11 - epoxide, and 10 - hydroxycarbazepine [ J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub ,2007,151 (1) :91 -94.
  • 10Pauletto G, Bergonzi P, Triveneto Epilepsy Study Group. Oxcarbazepine reduces seizure frequency in a high proportion of patients with both newly diagnosed and refractory partial seizures in clinical practice [ J ]. Seizure,2006,15 ( 3 ) : 150 - 155.

共引文献106

同被引文献15

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部